| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +25.00% | +5.53% | +1.56% | +3.97% | +3.71% | — |
| 14d | 4 | +25.00% | +3.52% | +2.11% | +1.41% | +1.18% | — |
| 30d | 4 | +75.00% | -6.25% | +0.74% | -7.00% | -7.87% | — |
| 60d | 4 | +75.00% | -9.48% | -0.61% | -8.87% | -9.62% | — |
| 90d | 4 | +100.00% | -13.50% | +1.86% | -15.36% | -15.48% | — |
| 180d | 4 | +75.00% | -11.03% | +6.82% | -17.84% | -27.91% | — |
| 1y | 4(1 pending) | +100.00% | -20.66% | +13.71% | -34.37% | -38.75% | — |
| 2y | 4(1 pending) | +100.00% | -28.22% | +24.28% | -52.49% | -65.26% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 7,751 | — | — | 25,423 | Mar 5, 2026 | Mar 23, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 8,315 | — | — | 8,315 | Mar 5, 2026 | Mar 23, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 62 | $125.84 | $7.8K | 17,672 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 125 | — | — | 17,734 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 2,433 | $124.97 | $304.1K | 17,609 | Mar 2, 2026 | Mar 3, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 1,478 | $128.73 | $190.3K | 20,042 | Feb 27, 2026 | Mar 3, 2026 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 2,191 | $151.21 | $331.3K | 21,520 | Nov 18, 2025 | Nov 19, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 454 | $128.50 | $58.3K | 23,711 | Apr 1, 2025 | Apr 2, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 175 | $142.44 | $24.9K | 24,165 | Mar 13, 2025 | Mar 20, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 381 | — | — | 24,340 | Mar 13, 2025 | Mar 20, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 6,435 | — | — | 25,198 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 1,239 | $155.38 | $192.5K | 23,959 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 6,056 | — | — | 6,056 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 1,285 | $156.54 | $201.2K | 18,763 | Feb 27, 2025 | Feb 28, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 543 | $164.74 | $89.5K | 20,048 | Feb 24, 2025 | Feb 25, 2025 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 444 | $182.95 | $81.2K | 20,591 | Apr 2, 2024 | Apr 4, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 1,206 | $195.72 | $236.0K | 21,035 | Mar 7, 2024 | Mar 7, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 22 | $195.52 | $4.3K | 22,241 | Mar 5, 2024 | Mar 6, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 197 | $193.99 | $38.2K | 22,263 | Mar 4, 2024 | Mar 6, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 820 | $191.79 | $157.3K | 22,410 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 50 | — | — | 22,460 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 404 | — | — | 23,230 | Feb 29, 2024 | Mar 4, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 8,691 | — | — | 22,826 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 8,632 | — | — | 8,632 | Feb 27, 2024 | Feb 29, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASE Chief Operating Officer | 940 | $94.33 | $88.7K | 18,508 | Feb 23, 2024 | Feb 26, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 4,373 | $198.08 | $866.2K | 14,135 | Feb 23, 2024 | Feb 26, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASE Chief Operating Officer | 940 | — | — | 4,000 | Feb 23, 2024 | Feb 26, 2024 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 334 | $163.45 | $54.6K | 17,568 | Apr 4, 2023 | Apr 4, 2023 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 210 | $188.00 | $39.5K | 17,902 | Mar 3, 2023 | Mar 6, 2023 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 625 | — | — | 18,112 | Mar 3, 2023 | Mar 6, 2023 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 8,644 | — | — | 8,644 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 8,348 | — | — | 17,487 | Mar 2, 2023 | Mar 6, 2023 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 594 | $173.44 | $103.0K | 9,139 | Feb 28, 2023 | Feb 28, 2023 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 2,000 | $240.40 | $480.8K | 9,733 | Aug 3, 2022 | Aug 4, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 2,000 | — | — | 8,000 | Aug 3, 2022 | Aug 4, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASE Chief Operating Officer | 2,000 | $94.33 | $188.7K | 11,733 | Aug 3, 2022 | Aug 4, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 335 | $188.02 | $63.0K | 9,733 | Apr 1, 2022 | Apr 4, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 4,312 | — | — | 4,312 | Feb 24, 2022 | Feb 28, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 188 | $189.21 | $35.6K | 10,068 | Feb 24, 2022 | Feb 28, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 3,366 | — | — | 10,256 | Feb 24, 2022 | Feb 28, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | PURCHASEGRANT Stock grant | 900 | — | — | 7,224 | Feb 17, 2022 | Feb 22, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | SALE Chief Operating Officer | 334 | $182.42 | $60.9K | 6,890 | Feb 17, 2022 | Feb 22, 2022 ↗ | View → |
| RGEN REPLIGEN CORP | SALE SVP, Global Operations & IT | 360 | $204.25 | $73.5K | 6,324 | Apr 6, 2021 | Apr 8, 2021 ↗ | View → |